TotalMarketCap

MBX Biosciences

MBXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.340 B

$48.59 -7.41%

Close of 6 Nov 2026

As of 6 Nov 2026, MBX Biosciences (MBX) has a market capitalization of $2.34B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$87.0M

Loss-making

Shares outstanding

48,160,096

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #82Palvella TherapeuticsPVLA$2.48B
  2. #83Xeris BiopharmaXERS$2.37B
  3. #84MBX BiosciencesMBX$2.34B
  4. #85PharvarisPHVS$2.28B
  5. #86NewAmsterdam PharmaNAMS$2.27B

What if MBX Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$586,312.66

Per share 12,067× higher

Bitcoin $1.53T

$31,724.36

Per share 653× higher

Apple $5.02T

$104,148.10

Per share 2,143× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for MBX Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.